Table of Content



Chapter 1 Executive Summary
1.1 Market Summary
Chapter 2 Legal Cannabis Market: Variables, Trends & Scope
2.1 Estimated Number of Cannabis Users from 2016 to 2026, by Country
2.1.1 Estimated Number of Medical Marijuana Users from 2016 to 2026, by Country
2.2 Legal Cannabis Regulatory Scenario, By Country
2.2.1 Australia
2.2.1.1 Overview
2.2.1.2 Cultivation
2.2.1.3 Manufacturing
2.2.1.4 Regulatory Bodies Involved
2.2.2 U.S.
2.2.2.1 Overview
2.2.2.2 Cultivation
2.2.2.3 Regulatory Bodies Involved
2.2.3 Canada
2.2.3.1 Overview
2.2.3.2 Cultivation
2.2.3.3 Production
2.2.3.4 Regulatory Bodies Involved
2.2.4 Germany
2.2.4.1 Overview
2.2.4.2 Cultivation/Production
2.2.4.3 Regulatory Bodies Involved
2.2.5 Italy
2.2.5.1 Overview
2.2.5.2 Cultivation
2.2.5.3 Regulatory Bodies Involved
2.2.6 The Netherlands
2.2.6.1 Overview
2.2.6.2 Cultivation
2.2.6.3 Regulatory Bodies Involved
2.2.7 Czech Republic
2.2.7.1 Overview
2.2.7.2 Cultivation/Production
2.2.7.3 Regulatory Bodies Involved
2.2.8 Poland
2.2.8.1 Overview
2.2.8.2 Cultivation/Production
2.2.8.3 Regulatory Bodies Involved
2.2.9 Switzerland
2.2.9.1 Overview
2.2.9.2 Cultivation/Production
2.2.9.3 Regulatory Bodies Involved
2.2.10 New Zealand
2.2.10.1 Overview
2.2.10.2 Cultivation/Production
2.2.10.3 Regulatory Bodies Involved
2.2.11 Thailand
2.2.11.1 Overview
2.2.11.2 Cultivation/Production
2.2.11.3 Regulatory Bodies Involved
2.2.12 Japan
2.2.12.1 Overview
2.2.12.2 Cultivation/Production
2.2.12.3 Regulatory Bodies Involved
2.2.13 South Korea
2.2.13.1 Overview
2.2.13.2 Cultivation/Production
2.2.13.3 Regulatory Bodies Involved
2.3 Market Dynamics
2.3.1 Market Driver Analysis
2.3.1.1 Growing legalization of medical marijuana in various countries
2.3.1.2 Growing adoption of medical marijuana for treatment of chronic diseases
2.3.1.3 Increasing demand of cannabis driving cannabis cultivation across the globe
2.3.1.4 Elimination of black market through legalization of medical marijuana
2.3.1.5 Impending legalization of marijuana for recreational/adult use
2.3.1.6 Increasing need for potent cannabis and recent technological advancements
2.3.1.7 Increasing preference towards cannabis extracts such as oils and tinctures
2.3.1.8 Growing legalization of cannabis-based CBD products
2.3.1.9 Growing adoption of CBD-based products for treating various medical conditions
2.3.1.10 Rise in the number of retailers selling CBD-based products
2.3.2 Market Restraint Analysis
2.3.2.1 Absence of legalization programs in several Asian and African countries
2.3.2.2 Strict government regulations
2.3.2.3 Legalization of medical cannabis only for selected indications
2.3.2.4 High pricing of medical cannabis
2.3.2.5 High pricing of cannabis compared to illegal markets in the U.S.
2.3.2.6 Illicit cananbis trade
2.3.3 Industry Challenges
2.3.3.1 Incomplete evidence regarding the effectiveness of medical marijuana
2.3.3.2 Reluctance of doctors to prescribe cannabis
2.3.3.3 Lower market access to cannabis due to absence of legalization programs, leading to smuggling
2.4 Industry Analysis -SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
2.4.1 Political and Legal Landscape
2.4.2 Economic and Social Landscape
2.4.3 Technology Landscape
2.5 Cannabinoid Summary
2.5.1 Cannabidiol (CBD)
2.5.2 Tetrahydrocannabinol (THC)
2.5.3 Cannbinol (CBN)
2.5.4 CBG
2.5.5 Terpenes
2.5.6 Flavonoids
2.5.7 cannabinoid Acids
2.5.8 Entourage Effect
2.6 Analysis on Mode of Ingestion
2.7 Cannabis Pricing Analysis, By Country, 2019 - 2026 (USD)
Chapter 3 Legal Cannabis Market: Product Type Estimates & Trend Analysis
3.1 Market Definition
3.2 Legal Cannabis Market: Product Type Movement Analysis
3.3 Legal Cannabis Market: Product Type Analysis
3.3.1 Hemp Oil (Whole Plant/CBD Oil)
3.3.1.1 Hemp Oil (Whole Plant/CBD Oil) Market Estimates and Forecasts, 2016 - 2026 (USD Million)
3.3.2 Marijuana
3.3.2.1 Marijuana Market Estimates and Forecasts, 2016 - 2026 (USD Million)
3.3.2.2 Flower
3.3.2.3 Oil
3.3.2.4 Tincture
Chapter 4 Cannabis Opportunity Analysis
4.1 Chronic Pain
4.1.1 Global Chronic Pain Therapeutics Market Estimates, Forecasts & Trends Analysis, 2016 - 2026
4.1.2 Global Opioid Market Estimates, Forecasts & Trends Analysis, 2016 - 2026
4.1.3 Estimated Number of Opioid Users from 2016 to 2026, by Country
4.1.4 Estimated Number of Chronic Pain Patients from 2016 to 2026, by Country
4.1.5 Comparative Analysis on the use of Cannabis Vs Opioid in Chronic Pain
4.1.6 Economic Cost Analysis on Opioid Misuse, by Country
4.1.6.1 U.S.
4.1.6.2 Canada
4.1.6.3 Germany
4.1.6.4 Italy
4.1.6.5 Poland
4.1.6.6 Czech Republic
4.1.6.7 Switzerland
4.1.6.8 Netherlands
4.1.6.9 Australia
4.1.6.10 New Zealand
4.1.6.11 Thailand
4.1.6.12 Japan
4.1.6.13 South Korea
4.2 Inflammation
4.2.1 Global Inflammation Therapeutics Market Size 2016 to 2026
4.2.2 Estimated Number of Inflammation Patients, from 2016 to 2026, by Country
4.2.3 Comparative Analysis on the use of Cannabis Vs Inflammation Therapeutics
4.3 Anxiety
4.3.1 Global Anxiety Therapeutics Market Size 2016 to 2026
4.3.2 Estimated Number of Anxiety Patients, from 2016 to 2026, by Country
4.3.3 Comparative Analysis on the use of Cannabis Vs Anxiety Therapeutics in Anxiety Patients
Chapter 5 Legal Cannabis Market: Application Estimates & Trend Analysis
5.1 Legal Cannabis Market: Application Movement Analysis
5.2 Legal Cannabis Market: Application Analysis
5.2.1 Medical Use
5.2.1.1 Medical Use Market Estimates and Forecasts, 2016 - 2026 (USD Million)
5.2.1.2 Chronic Pain
5.2.1.3 Anxiety
5.2.1.4 Inflammation
5.2.1.5 Sleep Disorders
5.2.1.6 Others
5.2.2 B2B Channel
5.2.2.1 B2B Channel Market Estimates and Forecasts, 2016 - 2026 (USD Million)
5.2.3 Adult Use
5.2.3.1 Adult use Market Estimates and Forecasts, 2016 - 2026 (USD Million)
Chapter 6 Legal Cannabis Market: Regional Estimates & Trend Analysis
6.1 Legal Cannabis Market: Country Analysis, 2019 & 2026
6.1.1 U.S.
6.1.1.1 U.S. Legal Cannabis Market Estimates and Forecasts, 2016 - 2026 (USD Million)
6.1.2 Canada
6.1.2.1 Canada Legal Cannabis Market Estimates and Forecasts, 2016 - 2026 (USD Million)
6.1.3 Germany
6.1.3.1 Germany Legal Cannabis Market Estimates and Forecasts, 2016 - 2026 (USD Million)
6.1.4 Italy
6.1.4.1 Italy Legal Cannabis Market Estimates And Forecasts, 2016 - 2026 (USD Million)
6.1.5 Poland
6.1.5.1 Poland Legal Cannabis Market Estimates and Forecasts, 2016 - 2026 (USD Million)
6.1.6 Czech Republic
6.1.6.1 Czech Republic Legal Cannabis Market Estimates And Forecasts, 2016 - 2026 (USD Million)
6.1.7 Switzerland
6.1.7.1 Switzerland Legal Cannabis Market Estimates and Forecasts, 2016 - 2026 (USD Million)
6.1.8 Netherlands
6.1.8.1 Netherlands Legal Cannabis Market Estimates and Forecasts, 2016 - 2026 (USD Million)
6.1.9 Australia
6.1.9.1 Australia Legal Cannabis Market Estimates and Forecasts, 2016 - 2026 (USD Million)
6.1.10 New Zealand
6.1.10.1 New Zealand Legal Cannabis Market Estimates and Forecasts, 2016 - 2026 (USD Million)
6.1.11 Japan
6.1.11.1 Japan Legal Cannabis Market Estimates and Forecasts, 2016 - 2026 (USD Million)
6.1.12 South Korea
6.1.12.1 South Korea Legal Cannabis Market Estimates and Forecasts, 2016 - 2026 (USD Million)
6.1.13 Thailand
6.1.13.1 Thailand Legal Cannabis Market Estimates and Forecasts, 2016 - 2026 (USD Million)
Chapter 7 Cannabis Pharmaceuticals Market Estimates & Trend Analysis
7.1 Cannabis Pharmaceuticals Market
7.1.1 Europe
7.1.1.1 Germany
7.1.1.2 Italy
7.1.1.3 Netherlands
7.1.1.4 Poland
7.1.1.5 Czech Republic
7.1.1.6 Switzerland
7.1.2 Asia Pacific
7.1.2.1 Australia
7.1.2.2 New Zealand
7.1.2.3 South Korea
7.1.2.4 Japan
Chapter 8 Cannabis Nutraceuticals Market Estimates & Trend Analysis
8.1 Nutraceutical Market Definition
8.2 Cannabis Nutraceuticals Market
8.2.1 Asia Pacific
8.2.1.1 Australia
8.2.1.2 New Zealand
8.2.1.3 Thailand
8.2.1.4 Japan
8.2.1.5 South Korea
Chapter 9 Competitive Landscape
9.1 Company Profiles: International Players
9.1.1 Canopy Growth Corporation
9.1.1.1 Company overview
9.1.1.2 Financial performance
9.1.1.3 Strategic initiatives
9.1.2 Aphria, Inc
9.1.2.1 Company overview
9.1.2.2 Financial performance
9.1.2.3 Strategic initiatives
9.1.3 Aurora Cannabis
9.1.3.1 Company overview
9.1.3.2 Financial performance
9.1.3.3 Strategic initiatives
9.1.4 Tilray
9.1.4.1 Company overview
9.1.4.2 Financial performance
9.1.4.3 Strategic initiatives
9.1.5 GW Pharmaceuticals, plc.
9.1.5.1 Company overview
9.1.5.2 Financial performance
9.1.5.3 Strategic initiatives
9.1.6 Organigram holdings Inc.
9.1.6.1 Company overview
9.1.6.2 Financial performance
9.1.6.3 Strategic initiatives
9.1.7 Lexaria Bioscience Corp.
9.1.7.1 Company overview
9.1.7.2 Financial performance
9.1.7.3 Strategic Initiatives
9.1.8 ABcann Medicinals Inc. (PArt of VIVO Cannabis Inc.)
9.1.8.1 Company overview
9.1.8.2 Financial performance
9.1.8.3 Strategic Initiatives
9.1.9 The Cronos Group
9.1.9.1 Company overview
9.1.9.2 Financial performance
9.1.9.3 Strategic Initiatives
9.2 Company Profiles: ASX Listed Cannabis Companies
9.2.1 AusCann Group Holdings Pty Ltd
9.2.1.1 Company overview
9.2.1.2 Strategic initiatives
9.2.2 Cann Group Ltd.
9.2.2.1 Company overview
9.2.2.2 Financial performance
9.2.2.3 Strategic initiatives
9.2.3 Bod Australia
9.2.3.1 Company Overview
9.2.3.2 Financial Performance
9.2.3.3 Strategic Initiatives
9.2.4 Zelira Therapeutics
9.2.4.1 Company Overview
9.2.4.2 Strategic Initiatives
9.2.5 Althea Group Holdings Limited
9.2.5.1 Company Overview
9.2.5.2 Financial Performance
9.2.5.3 Strategic Initiatives
9.2.6 THC Global Group Ltd
9.2.6.1 Company Overview
9.2.6.2 Financial Performance
9.2.6.3 Strategic Initiatives
9.2.7 MGC Pharmaceuticals Ltd
9.2.7.1 Company Overview
9.2.7.2 Financial Performance
9.2.7.3 Strategic Initiatives
9.2.8 Ecofibre Limited
9.2.8.1 Company Overview
9.2.8.2 Financial Performance
9.2.8.3 Strategic Initiatives
Chapter 10 Methodology and Scope
10.1 Research Methodology
10.1.1 Information procurement
10.2 Information or Data Analysis
10.3 Market Formulation & Validation
10.3.1 Region Market: CAGR Calculation
10.4 Region Based Segment Share Calculation
10.5 List of Secondary Sources
10.6 List of Primary Sources



List of Tables



List of Tables



Table 1 Cannabis user pool analysis, by country, 2016 - 2026 (in thousands)
Table 2 Medical marijuana users pool analysis, by country, 2016 - 2026
Table 3 Average price of Marijuana per mg, by country, 2019 - 2026 (USD)
Table 4 Average price of Hemp CBD per mg, by country, 2019 - 2026 (USD)
Table 5 Opioid users pool analysis, by country, 2016 - 2026 (in thousands)
Table 6 Chronic pain patients, by country, 2016 - 2026 (in thousands)
Table 7 Inflammation patients, by country, 2016 - 2026 (in thousands)
Table 8 Anxiety patients, by country, 2016 - 2026 (in thousands)
Table 9 Europe cannabis pharmaceuticals market, by country, 2016 - 2026 (USD Million)
Table 10 Asia Pacific cannabis pharmaceuticals market, by country, 2016 - 2026 (USD Million)
Table 11 Australia cannabis nutraceuticals market, by product type, 2016 - 2026 (USD Million)
Table 12 New Zealand cannabis nutraceuticals market, by product type, 2016 - 2026 (USD Million)
Table 13 Thailand cannabis nutraceuticals market, by product type, 2016 - 2026 (USD Million)
Table 14 Japan cannabis nutraceuticals market, by product type, 2016 - 2026 (USD Million)
Table 15 South Korea cannabis nutraceuticals market, by product type, 2016 - 2026 (USD Million)
Table 16 Partial list of secondary sources
Table 17 Partial list of primary sources